H

Haemonetics Corp
D

HAE

53.710
USD
1.39
(2.66%)
مغلق
حجم التداول
37,915
الربح لكل سهم
4
العائد الربحي
-
P/E
16
حجم السوق
2,587,600,420
أصول ذات صلة
ABT
ABT
2.460
(1.90%)
131.760 USD
BDX
BDX
0.920
(0.47%)
195.920 USD
EW
EW
0.060
(0.08%)
78.250 USD
ISRG
ISRG
3.29
(0.69%)
480.08 USD
MDT
MDT
1.020
(1.11%)
93.000 USD
SYK
SYK
3.31
(0.87%)
381.81 USD
TMO
TMO
4.05
(0.83%)
489.18 USD
المزيد
الأخبار المقالات

العنوان: Haemonetics Corp

القطاع: Healthcare
الصناعة: Medical Devices
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.